Olmesartan, a novel AT1 antagonist, suppresses cytotoxic myocardial injury in autoimmune heart failure (Q46477791)

22 December 2017

title

Olmesartan, a novel AT1 antagonist, suppresses cytotoxic myocardial injury in autoimmune heart failure (English)

1 reference

22 December 2017

0 references

1 reference

Zuyi Yuan

1

1 reference

22 December 2017

Masaomi Nimata

2

1 reference

22 December 2017

Taka-Aki Okabe

3

1 reference

22 December 2017

Keisuke Shioji

4

1 reference

22 December 2017

Koji Hasegawa

5

1 reference

22 December 2017

Toru Kita

6

1 reference

22 December 2017

Chiharu Kishimoto

7

1 reference

22 December 2017

publication date

6 May 2005

1 reference

22 December 2017

American Journal of Physiology Heart and Circulatory Physiology

published in

1 reference

22 December 2017

volume

289

1 reference

22 December 2017

issue

3

1 reference

22 December 2017

page(s)

H1147-52

1 reference

22 December 2017

Angiotensin II type 1 receptor blockers

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00078.2005

Losartan, an angiotensin type 1 receptor antagonist, improves endothelial function in non-insulin-dependent diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00078.2005

Blockade of the angiotensin II type 1 receptor stabilizes atherosclerotic plaques in humans by inhibiting prostaglandin E2-dependent matrix metalloproteinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00078.2005

Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00078.2005

Antiinflammatory effects of angiotensin II subtype 1 receptor blockade in hypertensive patients with microinflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00078.2005

From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00078.2005

Additive beneficial effects of the combination of a calcium channel blocker and an angiotensin blocker on a hypertensive rat-heart failure model

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00078.2005

A novel experimental model of giant cell myocarditis induced in rats by immunization with cardiac myosin fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00078.2005

Angiotensin II receptor-independent antiinflammatory and antiaggregatory properties of losartan: role of the active metabolite EXP3179.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00078.2005

Interleukin 1 or tumor necrosis factor can promote Coxsackie B3-induced myocarditis in resistant B10.A mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00078.2005

Pharmacology of CS-866, a novel nonpeptide angiotensin II receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00078.2005

Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00078.2005

Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00078.2005

Overexpression of thioredoxin-1 in transgenic mice attenuates adriamycin-induced cardiotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00078.2005

Asymmetric dimethylarginine produces vascular lesions in endothelial nitric oxide synthase-deficient mice: involvement of renin-angiotensin system and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00078.2005

Olmesartan improves endothelin-induced hypertension and oxidative stress in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00078.2005

Beneficial effects of low-dose benidipine in acute autoimmune myocarditis: suppressive effects on inflammatory cytokines and inducible nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00078.2005

Cardioprotective effects of carvedilol on acute autoimmune myocarditis: anti-inflammatory effects associated with antioxidant property

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00078.2005

10.1152/AJPHEART.00078.2005

21 January 2018

Identifiers

DOI

1 reference

22 December 2017

1 reference

22 December 2017